HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Campaign Targets Unsupervised Pediatric Drug Ingestion

This article was originally published in The Tan Sheet

Executive Summary

The Consumer Healthcare Products Association, the Centers for Disease Control and Prevention and a public-private safe-medication initiative launch the “Up and Away and Out of Sight” campaign to educate caregivers about how to stop curious children from consuming drugs without supervision.

You may also be interested in...



OTC Industry Standardizes Pediatric Liquid Acetaminophen Concentration

Over-the-counter drug firms will make single-ingredient liquid acetaminophen pediatric products only in one standard concentration to help prevent dosing errors, their trade association said May 4.

Acetaminophen Awareness Coalition Prepares To Launch Education Campaign

Consumer health advocates, trade groups and FDA representatives are working together to raise awareness of safe acetaminophen use and to address an advisory committee's concerns about the painkiller.

Child-Resistant Packaging In The Works For More OTC Cold Products – CHPA

Leading OTC drug firms will voluntarily expand the use of child-resistant packaging to all cough/cold products while also considering new child-proof package designs to reduce the risk of accidental ingestion, the Consumer Healthcare Products Association says

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS125178

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel